Andrew T Nelson Selected Research

Andrew T Nelson Research Topics

5	Insulin Resistance 09/2023 - 01/2018
3	Inflammation (Inflammations) 09/2023 - 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2024
1	Frontotemporal Dementia (Semantic Dementia) 04/2024
1	Weight Gain 09/2023
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2023
1	Hemorrhage 12/2022
1	Paraproteinemias (Monoclonal Gammopathy) 12/2022
1	von Willebrand Diseases (von Willebrand's Disease) 12/2022
1	Obesity 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Infections 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Central Nervous System Protozoal Infections (Meningoencephalitis, Protozoal) 01/2018

5	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 01/2018
3	Insulin (Novolin)FDA Link 01/2021 - 01/2018
2	LipidsIBA 09/2023 - 01/2018
2	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021 - 01/2018
1	NucleotidesIBA 04/2024
1	GlobinsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 12/2022
1	Lenalidomide (CC 5013)FDA Link 12/2022
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022
1	Neuroprotective AgentsIBA 01/2022
1	Stearic AcidsIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	miltefosine (Impavido)IBA 01/2018
1	EstersIBA 01/2018
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2018
1	AcidsIBA 01/2018